26 May 2016
Instem plc
("Instem")
Result of Annual General Meeting
Instem (AIM: INS.L), a leading provider of IT solutions to the global early development healthcare market, announces that at its Annual General Meeting held today, all resolutions were duly passed.
For further information, please contact:
Instem plc |
Tel: +44 (0) 1785 825 600 |
Phil Reason, CEO |
www.instem.com |
Nigel Goldsmith, CFO |
|
|
|
N+1 Singer (Nominated Adviser & Broker) |
Tel: +44 (0) 20 7496 3000 |
Richard Lindley |
|
Nick Owen |
|
James White |
|
|
|
Walbrook PR Ltd |
Tel: +44 (0) 20 7933 8780 or |
Paul Cornelius |
instem@walbrookpr.com |
Sam Allen |
|
Helen Cresswell |
|
Paul Whittington |
|
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision-making leading to safer, more effective products.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem supports over 400 clients from offices in the United States, the United Kingdom, India, China and Japan, with an additional presence in France.
To learn more about Instem solutions and its mission, please visit www.instem.com